- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/08 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 237/08
Total number of patents in this class: 230
10-year publication summary
|
14
|
16
|
22
|
17
|
21
|
14
|
31
|
14
|
15
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4761 |
16 |
| Arvinas Operations, Inc. | 251 |
7 |
| Nodthera Limited | 45 |
7 |
| The Board of Trustees of the Leland Stanford Junior University | 6722 |
6 |
| Nippon Soda Co., Ltd. | 886 |
6 |
| Syngenta Crop Protection AG | 6789 |
5 |
| Idemitsu Kosan Co., Ltd. | 4285 |
5 |
| Mitsubishi Tanabe Pharma Corporation | 392 |
5 |
| F. Hoffmann-La Roche AG | 7792 |
4 |
| Genentech, Inc. | 4147 |
4 |
| Bayer Pharma AG | 1005 |
4 |
| Sumitomo Chemical Company, Limited | 8989 |
4 |
| Imago Biosciences, Inc. | 39 |
4 |
| Nocion Therapeutics, Inc. | 52 |
4 |
| BASF SE | 21318 |
3 |
| LG Chem, Ltd. | 17978 |
3 |
| E. I. du Pont de Nemours and Company | 3452 |
3 |
| CHDI Foundation, Inc. | 108 |
3 |
| Constellation Pharmaceuticals, Inc. | 218 |
3 |
| Kissei Pharmaceutical Co., Ltd. | 176 |
3 |
| Other owners | 131 |